Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta …
Drug Manufacturers - Specialty & Generic
US, Stoughton [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Collegium Pharmaceutical, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCollegium Pharmaceutical, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Collegium Pharmaceutical, Inc..
If you want to see a demo, head over to the financial segments of AAPL